Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan Refuses Compensation For All Hepatitis C Patients Given Bad Blood (Japan)

This article was originally published in PharmAsia News

Executive Summary

Japan will not compensate all patients given contaminated blood, the Health, Labor and Welfare minister says. The government and drug makers have been making deals to compensate some of the victims of contaminated blood that led them to contract hepatitis C. Many have filed suits, but Minister Yoichi Masuzoe said the government would agree only to compensate certain patients considered eligible and not to accept any settlement that fails to limit government and drug maker responsibility. The decision means a previous out-of-court settlement could collapse. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC065908

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel